430KRW
11.81 BKRW
215.69 BKRW
15.09 M
About DONGKOO BIO & PHARMA
Sector
CEO
Yong-Joon Cho
Headquarters
Seoul
Website
Employees (FY)
402
Founded
1970
ISIN
KR7006620009
FIGI
BBG00JQ1SYH4
DongKoo Bio & Pharm Co. Ltd. operates as a holding company engaged in the manufacture and sale of pharmaceutical products and health supplements. Its products include medicine, non-medical product information, contract manufacturing organization, medical apparatus, cosmetics, and household products such as starch spray and toothpaste. The company was founded in 1970 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 006620 is 6750 KRW — it has decreased by 2.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGKOO BIO & PHARMA stocks are traded under the ticker 006620.
006620 stock is 4.48% volatile and has beta coefficient of 0.65. Check out the list of the most volatile stocks — is DONGKOO BIO & PHARMA there?
Yes, you can track DONGKOO BIO & PHARMA financials in yearly and quarterly reports right on TradingView.
006620 stock has fallen by 1.46% compared to the previous week, the month change is a 9.58% rise, over the last year DONGKOO BIO & PHARMA has showed a 10.84% increase.
006620 net income for the last quarter is 5.07 B KRW, while the quarter before that showed 1.25 B KRW of net income which accounts for 307.15% change. Track more DONGKOO BIO & PHARMA financial stats to get the full picture.
Today DONGKOO BIO & PHARMA has the market capitalization of 190.77 B, it has increased by 10.27% over the last week.
Yes, 006620 dividends are paid annually. The last dividend per share was 120.00 KRW. As of today, Dividend Yield (TTM)% is 1.74%. Tracking DONGKOO BIO & PHARMA dividends might help you take more informed decisions.
DONGKOO BIO & PHARMA dividend yield was 2.12% in 2023, and payout ratio reached 28.06%. The year before the numbers were 1.79% and 46.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 006620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGKOO BIO & PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 402.00 employees. See our rating of the largest employees — is DONGKOO BIO & PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DONGKOO BIO & PHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DONGKOO BIO & PHARMA stock shows the buy signal. See more of DONGKOO BIO & PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGKOO BIO & PHARMA EBITDA is 20.64 B KRW, and current EBITDA margin is 9.57%. See more stats in DONGKOO BIO & PHARMA financial statements.